Mingli Chen, MD, MS, DABT, currently serves as the Vice President of Non-clinical Project Management at WuXi AppTec in Shanghai, where he leverages over 20 years of extensive experience in research and development, as well as safety assessment. His impressive career trajectory includes significant roles...
Mingli Chen, MD, MS, DABT, currently serves as the Vice President of Non-clinical Project Management at WuXi AppTec in Shanghai, where he leverages over 20 years of extensive experience in research and development, as well as safety assessment. His impressive career trajectory includes significant roles at leading pharmaceutical companies such as Pfizer, Novartis, Abbott, and MPI Research, where he honed his expertise in drug discovery, pharmacology, and clinical development.
In his current role, Mingli is instrumental in building and leading the Non-clinical Project Management team, focusing on integrating WuXi AppTec’s unique R&D services platform to meet the growing demands of regional and global Investigational New Drug (IND) enabling programs. His leadership is pivotal in advancing end-to-end integrated drug discovery and development projects, ensuring they progress smoothly into clinical trials. Mingli’s strategic vision encompasses not only the management of complex projects but also the enhancement of in vivo and in vitro methodologies, which are crucial for effective safety assessments and regulatory compliance.
Mingli's commitment to excellence in toxicology and drug development is evident in his previous role as Vice President of Toxicology Services at WuXi AppTec (Suzhou), where he successfully implemented innovative practices that improved project outcomes. His deep understanding of the pharmaceutical industry, combined with his proficiency in assay development and lifesciences, positions him as a key player in the evolution of non-clinical research. Through his efforts, Mingli Chen continues to drive advancements in drug development, ultimately contributing to the successful launch of new therapeutics that meet the needs of patients worldwide.
